{"product_id":"staar-marketing-mix","title":"STAAR Surgical Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBuilt for Strategy. Ready in Minutes.\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how STAAR Surgical’s product innovation, targeted pricing, distribution through specialist channels, and clinical-focused promotions combine to drive adoption in ophthalmic markets. This concise 4Ps snapshot highlights competitive strengths and gaps, then directs you to the full, editable Marketing Mix Analysis for deeper data, strategic recommendations, and ready-to-use slides. Purchase the complete report to save research time and apply proven tactics immediately.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEVO\/Visian ICL portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSTAAR’s core offering is the EVO\/Visian ICL family of implantable collamer lenses that correct myopia, hyperopia and astigmatism via intraocular implantation. The EVO\/Visian ICL is positioned as a premium, reversible alternative to laser vision correction emphasizing high-quality optics and minimal induced dry eye. Marketing highlights reversibility, stable refractive outcomes and patient suitability when corneal ablation is contraindicated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eToric and high-range corrections\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eToric ICLs correct astigmatism alongside spherical errors, expanding candidacy beyond pure myopes. High-diopter options reach patients outside typical laser ranges, enabling treatment of extreme refractive errors. This breadth lets clinics manage complex refractive profiles and increases case mix. It differentiates STAAR by refractive breadth and clinical versatility.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCollamer material \u0026amp; lens design\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eProprietary Collamer blends collagen copolymer for high biocompatibility and optical clarity, minimizing tissue response while maintaining refractive stability. Lens geometry promotes predictable, stable vaulting over the crystalline lens to reduce cataract risk and refractive surprises. Central port design (0.36 mm KS-Aquaport) supports physiological aqueous flow, improving safety and IOP predictability. Performance targets safety, predictability, and superior visual quality.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCataract IOLs and supporting optics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSTAAR also offers cataract IOLs and supporting optics that complement its refractive ICL portfolio, enabling surgeons to manage refractive and cataract cases across the patient vision-care journey. With over 20 million cataract surgeries globally annually (WHO range 2022–24) and a global IOL market ~3.7 billion USD in 2024, this diversification hedges procedural mix and broadens account relevance while reinforcing STAAR brand equity in premium intraocular optics.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eProduct role: Cataract IOLs complement ICLs\u003c\/li\u003e\n\u003cli\u003eMarket context: \u0026gt;20M surgeries\/yr (WHO 2022–24)\u003c\/li\u003e\n\u003cli\u003eMarket size: ~3.7B USD IOL market (2024)\u003c\/li\u003e\n\u003cli\u003eStrategic benefit: diversifies revenue base, strengthens premium optics positioning\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDelivery systems and customization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSingle-use injectors provide controlled Visian ICL insertion and reduce contamination risk, supporting predictable placement; lenses are sized using biometric inputs such as white-to-white and anterior chamber depth to optimize vault. Custom sterile packaging and procedure customization improve OR efficiency and visual outcomes; STAAR has delivered over 1 million implants worldwide by 2024.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eControlled insertion via single-use injectors\u003c\/li\u003e\n\u003cli\u003eBiometric sizing (WTW, ACD) to optimize vault\u003c\/li\u003e\n\u003cli\u003eSterile, customized packaging for surgical efficiency\u003c\/li\u003e\n\u003cli\u003eSystem-level value beyond implant\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEVO\/Visian ICLs: reversible, biocompatible vision correction with OR-ready injectors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSTAAR’s EVO\/Visian ICL family delivers premium, reversible correction for myopia, hyperopia and astigmatism with Collamer biocompatibility, central port safety and predictable vaulting. Single-use injectors, biometric sizing and sterile packaging support OR efficiency and outcomes. Portfolio includes cataract IOLs, diversifying exposure amid a ~3.7B USD IOL market and \u0026gt;20M cataract surgeries\/yr; \u0026gt;1M ICLs implanted by 2024.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003cth\u003eSource (yr)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eICL implants\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;1,000,000\u003c\/td\u003e\n\u003ctd\u003eSTAAR (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIOL market\u003c\/td\u003e\n\u003ctd\u003e~3.7B USD\u003c\/td\u003e\n\u003ctd\u003eMarket data (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCataract surgeries\/yr\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;20,000,000\u003c\/td\u003e\n\u003ctd\u003eWHO (2022–24)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise, company-specific deep dive into STAAR Surgical’s Product, Price, Place, and Promotion strategies, using real brand practices and competitive context to ground recommendations for managers, consultants, and marketers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses STAAR Surgical's 4P marketing analysis into a concise, actionable snapshot that relieves stakeholder pain by clarifying pricing, product positioning, promotion channels, and placement strategy for faster decisions and cross‑functional alignment. Ideal for leadership briefings, rapid strategy sessions, and plug‑and‑play inclusion in decks.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSurgeon-only clinical channel\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSurgeon-only clinical channel supplies ICLs exclusively to board-certified ophthalmic surgeons and refractive centers, targeting practices equipped for intraocular procedures. Direct engagement with clinics and surgeon training supports proper indication and patient selection, underpinning safety and outcomes. The channel has supported hundreds of thousands of EVO\/ICl procedures globally, preserving product integrity and clinical results.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal distributors and direct sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSTAAR Surgical uses a hybrid go-to-market model with direct sales in key markets and regional distributors covering 75+ countries. Local partners handle in-country logistics, regulatory compliance, and service, shortening time-to-patient and reducing operational complexity. Coverage spans North America, EMEA, APAC, and Latin America, balancing broad reach with specialist local support.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and market access\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAvailability is tied to jurisdictional regulatory approvals, notably FDA clearance for the EVO ICL in 2022, with STAAR's portfolio now sold in 75+ countries. Market entry is sequenced via regulatory approval, local reimbursement pathways and KOL adoption to drive uptake. Labeling and surgeon training are localized to local standards and languages. This framework supports compliant, consistent clinical use and broader adoption.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMade-to-order and inventory hubs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMade-to-order sizing for STAAR Surgical products links SKUs to patient biometrics, so many lenses are built-to-order and tracked by batch; regional inventory hubs and demand forecasting shorten delivery for common sizes and support OR schedules. Sterile handling and tight shelf-life controls are standard; cold-chain is generally not required.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eBuilt-to-order SKUs tied to biometric data\u003c\/li\u003e\n\u003cli\u003eRegional hubs + forecasting reduce lead times\u003c\/li\u003e\n\u003cli\u003eSterile handling; strict shelf-life management\u003c\/li\u003e\n\u003cli\u003eFulfillment aligned to OR timing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIn-theater training and service\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpin-theater training and service by staar surgical field specialists staa supports onboarding case observation staff leveraging visian icl fda approval in to boost clinical confidence. practice development tools improve patient flow conversion technical support reduces variability risk while nearby teams increase loyalty reorder frequency.\u003e\n\u003cp class=\"lst_crct\"\u003e\n\u003c\/p\u003e\u003cli\u003eField specialists: onsite onboarding \u0026amp; case support\u003c\/li\u003e\n\u003cli\u003ePractice resources: higher conversion, smoother flow\u003c\/li\u003e\n\u003cli\u003eTechnical support: fewer complications, consistency\u003c\/li\u003e\n\u003cli\u003eService proximity: increased loyalty and reorders\u003c\/li\u003e\n\u003c\/pin-theater\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSurgeon-channel ICL supply: built-to-order biometrics, regional hubs, FDA cleared (2018, 2022)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSurgeon-only clinical channel supplies ICLs to board-certified ophthalmic surgeons and refractive centers, supported by direct sales in key markets and distributors across 75+ countries. Built-to-order SKUs tied to biometrics use regional hubs and forecasting to shorten lead times for hundreds of thousands of global EVO\/ICL procedures. FDA clearances: EVO 2022; Visian ICL 2018.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGeographic reach\u003c\/td\u003e\n\u003ctd\u003e75+ countries\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProcedures (cumulative)\u003c\/td\u003e\n\u003ctd\u003eHundreds of thousands\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGo‑to‑market\u003c\/td\u003e\n\u003ctd\u003eDirect + regional distributors\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKey FDA dates\u003c\/td\u003e\n\u003ctd\u003eEVO 2022; Visian 2018\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eSame Document Delivered\u003c\/span\u003e\u003cbr\u003eSTAAR Surgical 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual STAAR Surgical 4P's Marketing Mix Analysis you'll receive instantly after purchase—no surprises. This same comprehensive, editable document covers Product, Price, Place and Promotion and is fully complete and ready to use. Download the exact file shown here immediately after checkout.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56164793319801,"sku":"staar-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/staar-marketing-mix.png?v=1762740006","url":"https:\/\/portersfiveforce.com\/products\/staar-marketing-mix","provider":"Porter's Five Forces","version":"1.0","type":"link"}